Thermo Fisher Scientific Gross Margin 2010-2025 | TMO
Current and historical gross margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current gross profit margin for Thermo Fisher Scientific as of March 31, 2025 is %.
| Thermo Fisher Scientific Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $42.90B | $17.73B | 41.34% |
| 2024-12-31 | $42.88B | $17.70B | 41.28% |
| 2024-09-30 | $42.37B | $17.27B | 40.77% |
| 2024-06-30 | $42.35B | $17.26B | 40.76% |
| 2024-03-31 | $42.49B | $17.17B | 40.40% |
| 2023-12-31 | $42.86B | $17.10B | 39.90% |
| 2023-09-30 | $43.42B | $17.31B | 39.87% |
| 2023-06-30 | $43.52B | $17.30B | 39.75% |
| 2023-03-31 | $43.81B | $17.65B | 40.28% |
| 2022-12-31 | $44.92B | $18.97B | 42.24% |
| 2022-09-30 | $44.17B | $19.62B | 44.42% |
| 2022-06-30 | $42.82B | $19.97B | 46.63% |
| 2022-03-31 | $41.12B | $19.89B | 48.37% |
| 2021-12-31 | $39.21B | $19.64B | 50.08% |
| 2021-09-30 | $39.06B | $19.94B | 51.05% |
| 2021-06-30 | $38.25B | $19.62B | 51.29% |
| 2021-03-31 | $35.89B | $18.47B | 51.47% |
| 2020-12-31 | $32.22B | $16.00B | 49.67% |
| 2020-09-30 | $28.50B | $13.48B | 47.31% |
| 2020-06-30 | $26.25B | $11.92B | 45.39% |
| 2020-03-31 | $25.65B | $11.36B | 44.30% |
| 2019-12-31 | $25.54B | $11.33B | 44.35% |
| 2019-09-30 | $25.22B | $11.22B | 44.48% |
| 2019-06-30 | $24.87B | $11.07B | 44.51% |
| 2019-03-31 | $24.63B | $10.98B | 44.60% |
| 2018-12-31 | $24.36B | $10.86B | 44.57% |
| 2018-09-30 | $23.90B | $10.60B | 44.37% |
| 2018-06-30 | $23.09B | $10.29B | 44.55% |
| 2018-03-31 | $22.01B | $9.84B | 44.69% |
| 2017-12-31 | $20.92B | $9.45B | 45.17% |
| 2017-09-30 | $19.82B | $9.06B | 45.70% |
| 2017-06-30 | $19.20B | $8.81B | 45.90% |
| 2017-03-31 | $18.74B | $8.61B | 45.92% |
| 2016-12-31 | $18.27B | $8.37B | 45.82% |
| 2016-09-30 | $17.97B | $8.20B | 45.62% |
| 2016-06-30 | $17.61B | $8.03B | 45.60% |
| 2016-03-31 | $17.34B | $7.89B | 45.50% |
| 2015-12-31 | $16.97B | $7.76B | 45.72% |
| 2015-09-30 | $16.81B | $7.74B | 46.05% |
| 2015-06-30 | $16.85B | $7.79B | 46.23% |
| 2015-03-31 | $16.91B | $7.70B | 45.52% |
| 2014-12-31 | $16.89B | $7.49B | 44.36% |
| 2014-09-30 | $15.86B | $6.88B | 43.39% |
| 2014-06-30 | $14.89B | $6.30B | 42.30% |
| 2014-03-31 | $13.80B | $5.81B | 42.11% |
| 2013-12-31 | $13.09B | $5.53B | 42.24% |
| 2013-09-30 | $12.88B | $5.43B | 42.17% |
| 2013-06-30 | $12.78B | $5.38B | 42.13% |
| 2013-03-31 | $12.65B | $5.34B | 42.24% |
| 2012-12-31 | $12.51B | $5.30B | 42.33% |
| 2012-09-30 | $12.30B | $5.20B | 42.29% |
| 2012-06-30 | $12.15B | $5.12B | 42.18% |
| 2012-03-31 | $11.90B | $4.96B | 41.73% |
| 2011-12-31 | $11.56B | $4.79B | 41.47% |
| 2011-09-30 | $11.05B | $4.59B | 41.49% |
| 2011-06-30 | $10.75B | $4.43B | 41.21% |
| 2011-03-31 | $10.49B | $4.32B | 41.15% |
| 2010-12-31 | $10.39B | $4.26B | 41.00% |
| 2010-09-30 | $10.49B | $4.19B | 39.91% |
| 2010-06-30 | $10.40B | $4.14B | 39.80% |
| 2010-03-31 | $10.28B | $4.08B | 39.64% |
| 2009-12-31 | $9.91B | $3.90B | 39.32% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $152.862B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.987B | 81.02 |
| Edwards Lifesciences (EW) | United States | $44.910B | 29.45 |
| Alcon (ALC) | Switzerland | $42.991B | 29.05 |
| IDEXX Laboratories (IDXX) | United States | $41.889B | 48.14 |
| DexCom (DXCM) | United States | $32.949B | 50.93 |
| IQVIA Holdings (IQV) | United States | $27.500B | 15.40 |
| Mettler-Toledo (MTD) | United States | $24.243B | 28.83 |
| STERIS (STE) | Ireland | $21.902B | 24.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.211B | 0.00 |
| Waters (WAT) | United States | $16.761B | 23.65 |
| Hologic (HOLX) | United States | $14.193B | 15.42 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Penumbra (PEN) | United States | $8.863B | 69.56 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $7.025B | 16.74 |
| Glaukos (GKOS) | United States | $5.527B | 0.00 |
| Teleflex (TFX) | United States | $4.852B | 8.01 |
| Integer Holdings (ITGR) | United States | $3.892B | 20.39 |
| TransMedics (TMDX) | United States | $3.505B | 76.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.157B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.309B | 13.75 |
| Nihon Kohden (NHNKY) | Japan | $2.170B | 24.88 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 16.97 |
| Veracyte (VCYT) | United States | $1.804B | 25.31 |
| Alphatec Holdings (ATEC) | United States | $1.506B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.56 |
| OPKO Health (OPK) | United States | $1.110B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.007B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.974B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.884B | 4.70 |
| IRadimed (IRMD) | United States | $0.714B | 36.25 |
| SiBone (SIBN) | United States | $0.710B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.620B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.547B | 11.77 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 8.19 |
| Pacific Biosciences Of California (PACB) | United States | $0.435B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.418B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.394B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.374B | 8.69 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| NeuroPace (NPCE) | United States | $0.307B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.225B | 13.61 |
| CVRx (CVRX) | United States | $0.216B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.00 |
| Hyperfine (HYPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.02 |